Optimizing Industrial Involvement with Medical Countermeasure Development: A Report of the National Biodefense Science Board   [open pdf - 597KB]

This document concludes that the U.S. government needs to collaborate much closer with private industry "to improve the nation's medical defenses against biological, chemical, radiological, and nuclear threats." The report lists the following as top-priority threats: "anthrax, botulism, filoviruses (Ebola and Marburg), glanders and meliodosis, Junin virus, plague, smallpox, tularemia, typhus, radiological and nuclear threats, and volatile nerve agents" and concludes with the following 8 specific recommendations to the U.S. government: "to harness the national industrial base, the U.S. Congress and the Executive Branch must provide adequate, consistent funding; the U.S. Government must accelerate the pace of MCM [medical countermeasures] development; the U.S. Government must centralize its leadership for MCM development and acquisition, and optimize distribution methods; the U.S. Government must demonstrate long-term commitment to its industry collaborators; the U.S. Government must create, sustain, and enhance innovative partnerships with private industry; the U.S. Government should expand MCM markets to include state and local first-responders and allied governments; the U.S. Government must do a better job of preparing for anticipatable emergencies; and various departments and agencies of the U.S. Government must act in concert to ensure success."

Public Domain
Retrieved From:
U.S. Department of Health and Human Services (HHS): http://www.hhs.gov/
Media Type:
Help with citations